Business Overview
KYORIN Pharmaceutical Co., Ltd. maintains an active role in providing benefit to people‘s health through revolutionary drug discoveries and the provision of reliable products and services.
New Medium-Term Business Plan Developed: "HOPE 100 Stage 1"
KYORIN Co., Ltd. has developed a new medium-term business plan for the KYORIN Group. The plan is called "HOPE 100 Stage 1" and covers the period from FY2010 to FY2015. Under the new plan, the KYORIN Group will strive to realize its corporate philosophy of cherishing life and benefiting society by contributing to better health.
New Drug Creativity
We identify the target that constitutes the cause of a disease and create the "seeds" for new drugs that contribute to its cure. In a nutshell, creative research is the essence of our work that is all about "creating something out of nothing."
Alliance Strategies
In an effort to enhance the efficiency of new drug development and to increase its sales potential, Kyorin also maintains a positive commitment to forming strategic alliances with leading companies both at home and abroad.
Research and Development
If we accept that drug creation research is the essence of our work of "creating 1 from 0" then our development research is the task of raising "1 to 100." Kyorin engages in research from all perspectives in order to develop the seeds created on the basis of drug creation research to the marketable drug level for world supply.
Production and Quality Warrant
For the manufacture of drugs that are safe for all patients taking them, it is of paramount importance to establish a Quality Assurance System in the production process. All Kyorin plants have a quality assurance system under Head Office control as part of the commitment to adhere to the highest standards of GMP in an effort to achieve the reliable supply of high-quality products.
MR Activities
As suggested by the Japanese description as "Medical Information Officer," the Medical Representative (MR) has the role of providing, gathering and transmitting information designed to promote correct drug use.
Healthcare
In the midst of the demographic changes toward a low-birthrate aging society, general awareness of "health" is bound to change also. In anticipation of the changes, Kyorin is active in the health business from the perception that the term "health" should be taken in a much broader meaning.
